Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Palatin Technologies (NY: PTN )

1.660 +0.030 (+1.84%)
Streaming Delayed Price Updated: 11:23 AM EDT, Sep 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 140,656
Open 1.620
Bid (Size) 1.580 (2)
Ask (Size) 1.670 (1)
Prev. Close 1.630
Today's Range 1.560 - 1.720
52wk Range 1.290 - 5.650
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development – Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions
Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development – Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions 
Via News Direct
Exposures Product Safety
PTN Stock Earnings: Palatin Techs Misses EPS for Q3 2024
PTN stock results show that Palatin Techs missed analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace

Performance

YTD
-56.99%
-56.99%
1 Month
+10.67%
+10.67%
3 Month
-11.70%
-11.70%
6 Month
-16.16%
-16.16%
1 Year
-29.06%
-29.06%

More News

Read More
Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data
Via Benzinga
Earnings Scheduled For February 15, 2024
Via Benzinga
Earnings Preview: Palatin Techs
Via Benzinga
Recap: Palatin Techs Q1 Earnings
Via Benzinga
Palatin Techs's Earnings Outlook
Via Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Palatin Technologies' Disappointing Data From Dry Eye Disease Study, Stock Plummets
Via Benzinga
Dow Dips 200 Points; TJX Posts Upbeat Sales
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The 3 Best Penny Stocks to Buy in February 2024
Via InvestorPlace
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
Via InvestorPlace
3 Penny Stocks to Buy to Unlock 2,500% Upside Potential
Via InvestorPlace
Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
From Cosette Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Analysts Say 3 Stocks Have a Combined Upside of 3000%
Via InvestorPlace
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders
Via FinancialNewsMedia
Earnings Scheduled For September 28, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.